AM-1241: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== AM-1241 == | |||
[[File:AM-1241-2D-skeletal.svg|thumb|right|200px|2D skeletal structure of AM-1241]] | |||
'''AM-1241''' is a synthetic [[cannabinoid]] that acts as a selective agonist for the [[cannabinoid receptor]] [[CB2 receptor|CB<sub>2</sub>]] subtype. It is known for its potential [[analgesic]] and [[anti-inflammatory]] properties, making it a subject of interest in [[medical research]]. | |||
AM-1241 is | |||
== | === Chemical Structure === | ||
AM-1241 | AM-1241 is characterized by its specific chemical structure, which allows it to selectively bind to the CB<sub>2</sub> receptors. The [[File:AM-1241-2D-skeletal.svg|thumb|left|200px|Chemical structure of AM-1241]] image illustrates the 2D skeletal structure of AM-1241, highlighting its key functional groups and molecular configuration. | ||
== | === Mechanism of Action === | ||
AM-1241 functions primarily by activating the CB<sub>2</sub> receptors, which are predominantly found in the [[immune system]] and [[peripheral nervous system]]. Unlike the [[CB1 receptor|CB<sub>1</sub>]] receptors, which are primarily located in the [[central nervous system]], CB<sub>2</sub> receptors do not produce the psychoactive effects typically associated with cannabinoids. This selective activation is believed to mediate the compound's analgesic and anti-inflammatory effects without the central side effects. | |||
== | === Potential Therapeutic Uses === | ||
Research into AM-1241 has suggested several potential therapeutic applications: | |||
==Related | * '''Pain Management''': Due to its action on CB<sub>2</sub> receptors, AM-1241 may be effective in managing [[chronic pain]] and [[neuropathic pain]]. | ||
* '''Inflammation''': Its anti-inflammatory properties make it a candidate for treating conditions characterized by excessive inflammation, such as [[arthritis]]. | |||
* '''Neuroprotection''': There is ongoing research into its potential neuroprotective effects, which could be beneficial in [[neurodegenerative diseases]]. | |||
=== Research and Development === | |||
AM-1241 is still under investigation, with studies focusing on its pharmacokinetics, safety profile, and efficacy in various [[animal models]]. The compound's ability to provide pain relief without the psychoactive effects of other cannabinoids makes it a promising candidate for further development. | |||
== Related Pages == | |||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[CB2 receptor]] | * [[CB2 receptor]] | ||
* [[ | * [[Analgesic]] | ||
* [[ | * [[Anti-inflammatory]] | ||
[[Category:Cannabinoids]] | [[Category:Cannabinoids]] | ||
[[Category: | [[Category:Pharmacology]] | ||
Latest revision as of 10:46, 15 February 2025
AM-1241[edit]

AM-1241 is a synthetic cannabinoid that acts as a selective agonist for the cannabinoid receptor CB2 subtype. It is known for its potential analgesic and anti-inflammatory properties, making it a subject of interest in medical research.
Chemical Structure[edit]
AM-1241 is characterized by its specific chemical structure, which allows it to selectively bind to the CB2 receptors. The

image illustrates the 2D skeletal structure of AM-1241, highlighting its key functional groups and molecular configuration.
Mechanism of Action[edit]
AM-1241 functions primarily by activating the CB2 receptors, which are predominantly found in the immune system and peripheral nervous system. Unlike the CB1 receptors, which are primarily located in the central nervous system, CB2 receptors do not produce the psychoactive effects typically associated with cannabinoids. This selective activation is believed to mediate the compound's analgesic and anti-inflammatory effects without the central side effects.
Potential Therapeutic Uses[edit]
Research into AM-1241 has suggested several potential therapeutic applications:
- Pain Management: Due to its action on CB2 receptors, AM-1241 may be effective in managing chronic pain and neuropathic pain.
- Inflammation: Its anti-inflammatory properties make it a candidate for treating conditions characterized by excessive inflammation, such as arthritis.
- Neuroprotection: There is ongoing research into its potential neuroprotective effects, which could be beneficial in neurodegenerative diseases.
Research and Development[edit]
AM-1241 is still under investigation, with studies focusing on its pharmacokinetics, safety profile, and efficacy in various animal models. The compound's ability to provide pain relief without the psychoactive effects of other cannabinoids makes it a promising candidate for further development.